UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000039708
Receipt No. R000045287
Scientific Title Study for the effects of molecular hydrogen on the cytokine and oxidative stress levels in pregnant women
Date of disclosure of the study information 2020/04/01
Last modified on 2020/03/05 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Study for the effects of molecular hydrogen on the cytokine and oxidative stress levels in pregnant women
Acronym Effects of molecular hydrogen on pregnancy
Scientific Title Study for the effects of molecular hydrogen on the cytokine and oxidative stress levels in pregnant women
Scientific Title:Acronym Effects of molecular hydrogen on pregnancy
Region
Japan

Condition
Condition pregnant women
Classification by specialty
Obsterics and gynecology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the relationship of maternal molecular hydrogen intake to cytokines and oxidative stress
Basic objectives2 Others
Basic objectives -Others To investigate the relationship of maternal molecular hydrogen intake to cytokines and oxidative stress, especially pro-inflammatory cytokines and 8OHdG
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes To investigate the relationship of molecular hydrogen intake to cytokines and oxidative stress in pregnant women
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Ingest a hydrogen-containing beverage that is licensed and commercial available as a health food. The intake should be 200-300mL / time x 1-3 times / day in principle. Therefore, the longest intake period is about 24 weeks.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
50 years-old >=
Gender Female
Key inclusion criteria All pregnant women over than or equal to 16 gestational-age and minimum age of 20 years
Key exclusion criteria Pregnant women, considered unsuitable for participation in this study by the investigators
Target sample size 50

Research contact person
Name of lead principal investigator
1st name Kenji
Middle name
Last name Imai
Organization Nagoya University Graduate School of Medicine
Division name Obstetrics and Gynecology
Zip code 466-8550
Address 65 Tsurumai-cho, Showa-ku, Nagoya, Japan
TEL 052-744-2261
Email kenchan2@med.nagoya-u.ac.jp

Public contact
Name of contact person
1st name Kenji
Middle name
Last name Imai
Organization Nagoya University Graduate School of Medicine
Division name Obstetrics and Gynecology
Zip code 466-8550
Address 65 Tsurumai-cho, Showa-ku, Nagoya, Japan
TEL 052-744-2261
Homepage URL
Email kenchan2@med.nagoya-u.ac.jp

Sponsor
Institute Nagoya University Graduate School of Medicine
Institute
Department

Funding Source
Organization MEXT
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Institutional Review Board of Nagoya University Graduate School of Medicine
Address 65 Tsurumai-cho, Showa-ku, Nagoya, Japan
Tel 052-744-2479
Email iga-shinsa@adm.nagoya-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 04 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2020 Year 03 Month 05 Day
Date of IRB
2020 Year 04 Month 01 Day
Anticipated trial start date
2020 Year 04 Month 01 Day
Last follow-up date
2028 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2020 Year 03 Month 05 Day
Last modified on
2020 Year 03 Month 05 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045287